The study of Ferensztajn-Rochowiak et al. compared serum levels of NMDA, GAD, and IGF-1 between BD patients during acute mania and depression, after remission, and under long-term lithium treatment. The gene discussed is IGF1; the disease is depressive symptom measurement.